By Dr Carlos Velez, expert trainer of Business Development & Licensing Course For Pharma & Biotech
and The AI for Pharma Business Development & Licensing Course
Innovation starts in the lab, but success depends on many factors: scientific excellence, execution, funding, and timing among them.
One capability that connects these elements and helps turn innovation into measurable value is business development and licensing (BD&L).
BD&L is often viewed as a final step in the process: the team that negotiates, signs agreements, and announces partnerships.
In reality, BD&L is a strategic capability that links science, finance, and corporate vision. It shapes how companies decide which assets to advance, who to partner with, and how to balance risk and reward across the portfolio.
When applied strategically, BD&L brings together diverse perspectives to answer key questions:
A mature BD&L capability blends multiple disciplines:
These elements rely on collaboration across functions, from R&D and finance to commercial, legal, and leadership teams.
No company succeeds on science alone.
As the industry becomes more interconnected, understanding the principles of business development helps teams across roles make better, faster, and more strategic decisions.
Building internal BD&L capabilities strengthens collaboration, enhances valuation discussions, and increases readiness for future opportunities.
Continue your learning from Dr Carlos Velez
If youâd like to learn more from Dr Carlos Velez, CELforPharma also offers the following 2 courses:
†BUSINESS DEVELOPMENT & LICENSING:
†AI IN PHARMA BD&L:
Donât miss the latest insights from our expert faculty
Subscribe to our newsletter to: